retatrutide ly3437943 parkinson's disease clinical trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a retatrutide ly3437943 parkinson's disease clinical

US$ 23.43

★★★★★ 4.0 (12 reviews)

US$ 24.31

★★★★★ 4.8 (26 reviews)

US$ 25.96

★★★★★ 4.7 (26 reviews)

US$ 29.33

★★★★★ 4.1 (21 reviews)

US$ 22.99

★★★★★ 4.1 (16 reviews)

US$ 23.88

★★★★★ 4.0 (15 reviews)

US$ 28.11

★★★★★ 4.1 (13 reviews)

US$ 24.92

★★★★★ 4.0 (19 reviews)

US$ 26.59

★★★★★ 4.2 (10 reviews)

US$ 29.66

★★★★★ 5.0 (22 reviews)

US$ 25.96

★★★★★ 4.1 (8 reviews)

US$ 25.44

★★★★★ 4.3 (28 reviews)

US$ 24.65

★★★★★ 4.6 (6 reviews)

US$ 21.59

★★★★★ 4.1 (18 reviews)

US$ 24.91

★★★★★ 4.7 (8 reviews)

US$ 28.55

★★★★★ 4.3 (20 reviews)

US$ 22.35

★★★★★ 4.9 (16 reviews)

US$ 27.82

★★★★★ 4.4 (11 reviews)

US$ 23.09

★★★★★ 4.9 (9 reviews)

US$ 23.59

★★★★★ 4.8 (25 reviews)